[SLN] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 40.51%
YoY- 28.46%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 2,798 3,371 3,156 1,988 122 0 0 -
PBT -10,661 -9,326 -12,052 -9,540 -6,636 -5,370 1,441 -
Tax -2,411 -2,223 -2,123 -462 950 507 508 -
NP -8,250 -7,103 -9,929 -9,078 -5,686 -4,862 1,949 -
Tax Rate - - - - - - -35.30% -
Total Cost 11,048 10,474 13,085 11,066 5,808 4,862 -1,949 -
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -294.85 -210.71 -314.61 -456.64 -4,660.66 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.22 -0.22 -0.33 -0.33 -0.22 -0.21 0.08 -
EPS Diluted -0.22 -0.22 -0.33 -0.33 -0.22 -0.21 0.08 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.